earnings beatAVIRfinnhub
Atea Pharmaceuticals (AVIR) Beats Q2 Earnings Estimates by $0.15
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreQT Imaging Holdings (NASDAQ:QTI) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreNano Nuclear Energy (NASDAQ:NNE) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreJourney Medical (NASDAQ:DERM) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreKura Oncology (NASDAQ:KURA) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreCyngn (NASDAQ:CYN) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreBioCardia (NASDAQ:BCDA) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreTalphera (NASDAQ:TLPH) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreLeslies (NASDAQ:LESL) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreWestern Forest Products (NASDAQ:WEF) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreOmeros (NASDAQ:OMER) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read morePerma-Fix Envirn Servs (NASDAQ:PESI) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreBeasley Broadcast Group (NASDAQ:BBGI) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreT1 Energy (NYSE:TE) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreMonopar Therapeutics (NASDAQ:MNPR) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreAprea Therapeutics (NASDAQ:APRE) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreSPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc. (NASDAQ:SPRB) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreAtara Biotherapeutics (NASDAQ:ATRA) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreArmata Pharmaceuticals (AMEX:ARMP) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreArriVent BioPharma (NASDAQ:AVBP) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read more